Skip to main content
Premium Trial:

Request an Annual Quote

Abnova to Distribute Olink Product Line in US

NEW YORK (GenomeWeb News) – Olink Bioscience today said that Abnova will distribute the firm's Duolink in situ PLATM product line in the US.

The agreement expands a previous pact between the firms, under which they agreed to co-develop and co-market hundreds of target-specific assays for studies of protein phosphorylation and protein interactions based on antibodies from Abnova and the Duolink product line.

Peter Karlberg, director of sales and marketing for Olink, said that Abnova is "a perfect partner for Olink Bioscience to accelerate our penetration of the US market and to establish Duolink as a standard for high-performance in situ studies of proteins, protein interactions and protein modifications."

Financial and other terms of the agreement were not disclosed.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.